Mathers Edward T. - 25 Jun 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jun 2025, 19:02:08 UTC
Prior SEC filing
26 Jun 2025
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Zachary Bambach, attorney-in-fact

Key filing fact

Mathers Edward T. filed Form 4 for Senti Biosciences, Inc. (SNTI) on 27 Jun 2025.

Key facts

  • This page summarizes Mathers Edward T.'s Form 4 filing for Senti Biosciences, Inc. (SNTI).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 Jun 2025, 19:02.

Change

  • Previous filing in this sequence was filed on 26 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001328625 Primary reporting owner

Mathers Edward T

Relationship
Director
Address
104 5TH AVE, 19TH FLOOR, NEW YORK
Signature
/s/ Zachary Bambach, attorney-in-fact
Signature date
27 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SNTI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+21,950
Change %
Price
$0.000000
Shares after
21,950
Date
25 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,950
Exercise price
$2.05
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .